Vemurafenib

BNF:
8.1.5
Status:
Red
Decision Date:
January 2013
 

Comments

RED:4 NICE TA269: Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma

Red Drug Classifications

  • 4: Specifically designated as “hospital only” by product licence or by DH/NICE

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app